Wednesday, April 21, 2021

Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection

Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery.

from Moneycontrol Business News https://ift.tt/2QKipoL

No comments:

Post a Comment

European shares log weekly losses on Iran war-linked inflation woesdrop

European markets experienced a significant downturn, with the STOXX 600 index sliding due to escalating energy inflation fears stemming from...